← Leaderboards
Michael Salvatore Conte
Brigham And Women'S Hospital
$9,171,065
Attributed
$9,920,596
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,920,596 · 10
By mechanism
U01$4,257,702 · 1
R01$3,492,184 · 2
R44$1,499,063 · 1
K08$535,680 · 1
M01$135,967 · 5
Top collaborators
- Kerstin Rebrin1 shared
- Natalie Ann Wisniewski1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Hadi Shafiee$15,983,059
- Dae Hyun Kim$10,266,963
- Frederic S Resnic$5,874,316
- Abeel A Mangi$54,460
- Peter Ganz$8,034,092
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelOperative Surgical ProceduresUnited StatesBlood VesselsHealingNovel StrategiesTechnologyQuality Of LifeAmputationPreventionTranslational ResearchVascular DiseasesMultidisciplinaryCaringMorbidity - Disease RateFundingRecurrenceBypassArteriesPeripheralProtocols DocumentationLimb StructureMortalityAngioplasty
Grant awards (29)
UCSF Diabetic Foot Clinical Research Unit$779,956
U01 · FY2025 · DK · contact PI
UCSF Diabetic Foot Clinical Research Unit$765,842
U01 · FY2024 · DK · contact PI
UCSF Diabetic Foot Clinical Research Unit$552,946
U01 · FY2023 · DK · contact PI
UCSF Diabetic Foot Clinical Research Unit$198,878
U01 · FY2023 · DK · contact PI
UCSF Diabetic Foot Clinical Research Unit$444,125
U01 · FY2022 · DK · contact PI
Admin Supplement Request for U01 DK119100-04$190,455
U01 · FY2022 · DK · contact PI
UCSF Diabetic Foot Clinical Research Unit$444,125
U01 · FY2020 · DK · contact PI
Tissue Oxygen Monitoring in Peripheral Vascular Disease$859,418
R44 · FY2019 · HL
UCSF Diabetic Foot Clinical Research Unit$441,375
U01 · FY2019 · DK · contact PI
Tissue Oxygen Monitoring in Peripheral Vascular Disease$639,645
R44 · FY2018 · HL
UCSF Diabetic Foot Clinical Research Unit$440,000
U01 · FY2018 · DK · contact PI
Specialized lipid mediators and mechanisms of resolution in vascular injury$396,250
R01 · FY2016 · HL · contact PI
Specialized lipid mediators and mechanisms of resolution in vascular injury$390,203
R01 · FY2015 · HL · contact PI
Specialized lipid mediators and mechanisms of resolution in vascular injury$386,896
R01 · FY2014 · HL · contact PI
Specialized lipid mediators and mechanisms of resolution in vascular injury$373,660
R01 · FY2013 · HL · contact PI
Survivin: a novel regulator of intimal hyperplasia and vein graft remodeling$386,250
R01 · FY2012 · HL · contact PI
Survivin: a novel regulator of intimal hyperplasia and vein graft remodeling$386,250
R01 · FY2010 · HL · contact PI
Survivin: a novel regulator of intimal hyperplasia and vein graft remodeling$386,250
R01 · FY2009 · HL · contact PI
Survivin: a novel regulator of intimal hyperplasia and vein graft remodeling$380,800
R01 · FY2008 · HL · contact PI
INFLAMMATION AND INSULIN RESISTANCE IN PERIPHERAL ARTERY DISEASE$7,022
M01 · FY2008 · RR · contact PI
ADAPTATION AS A PREDICTOR OF ARTERIOVENOUS FISTULA SUCCESS$1,641
M01 · FY2008 · RR · contact PI
Survivin: a novel regulator of intimal hyperplasia and vein graft remodeling$405,625
R01 · FY2007 · HL · contact PI
INFLAMMATION AND INSULIN RESISTANCE IN PERIPHERAL ARTERY DISEASE$47,064
M01 · FY2007 · RR · contact PI
ADAPTATION AS A PREDICTOR OF ARTERIOVENOUS FISTULA SUCCESS$11,002
M01 · FY2007 · RR · contact PI
INFLAMMATION AND INSULIN RESISTANCE IN PERIPHERAL ARTERY DISEASE$69,238
M01 · FY2006 · RR · contact PI
GENETIC ENGINEERING OF A FAILURE RESISTANT VEIN GRAFT$133,920
K08 · FY2003 · HL
GENETIC ENGINEERING OF A FAILURE RESISTANT VEIN GRAFT$133,920
K08 · FY2002 · HL
GENETIC ENGINEERING OF A FAILURE RESISTANT VEIN GRAFT$133,920
K08 · FY2001 · HL
GENETIC ENGINEERING OF A FAILURE RESISTANT VEIN GRAFT$133,920
K08 · FY2000 · HL